Carboxypeptidase A

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 42: Line 42:
==Catalytic and Inhibitory Zinc Binding==
==Catalytic and Inhibitory Zinc Binding==
-
As previously stated, <scene name='69/694222/1cpx_default/3'>CPA</scene> from ''B. taurus'' has the ability to bind two Zn<sup>2+</sup> ions in its active site. The binding of only one Zn<sup>2+</sup> ion is [http://en.wikipedia.org/wiki/Catalysis catalytic], while the binding of a second is [http://en.wikipedia.org/wiki/Reaction_inhibitor inhibitory]. These Zn<sup>2+</sup> ions are connected to each other via a hydroxy-bridge (Figure 4) with a distance of 3.48 [http://en.wikipedia.org/wiki/%C3%85ngstr%C3%B6m Å].<ref name="CPA1" /> [[Image:1CPXhydroxybridge.png|150 px|right|thumb|Figure 4: Hydroxy-bridge between catalytic and inhibitory zinc ions. The catalytic Zn<sup>2+</sup> ion (shown in orange on the right) is bridged to the inhibitory Zn<sup>2+</sup> ion (shown in orange on the left) by a OH<sup>-</sup> (shown in red).]] In the CPA structure containing only the catalytic Zn<sup>2+</sup> ion (3CPA), a water molecule complexed to the zinc is able to be deprotonated by <scene name='69/694222/3cpas1subsiteglu270/3'>Glu270</scene> to allow for normal initiation of hydrolysis. Again, this water molecule was not crystallized in the structure of 3CPA, but it is shown in Figure 3. However, when <scene name='69/694222/Glu270wiz/8'>the inhibitory zinc ion</scene> is also present ([http://www.rcsb.org/pdb/explore/explore.do?structureId=1cpx 1CPX]), it occupies the physical space that would normally be occupied by the water molecule. Thus, the inhibitory Zn<sup>2+</sup> ion interacts with the carboxylate group of Glu270. The Glu270 (shown in yellow) now simply stabilizes the second Zn<sup>2+</sup> and is unable to perform its usual base catalyst role while the catalytic Zn<sup>2+</sup> ion (shown in cyan) is still being stabilized in place by His69, Glu72, and His196 (shown in orange).
+
As previously stated, <scene name='69/694222/1cpx_default/3'>CPA</scene> from ''B. taurus'' has the ability to bind two Zn<sup>2+</sup> ions in its active site. The binding of only one Zn<sup>2+</sup> ion is [http://en.wikipedia.org/wiki/Catalysis catalytic], while the binding of a second is [http://en.wikipedia.org/wiki/Reaction_inhibitor inhibitory]. These Zn<sup>2+</sup> ions are connected to each other via a hydroxy-bridge (Figure 4) with a distance of 3.48 [http://en.wikipedia.org/wiki/%C3%85ngstr%C3%B6m Å].<ref name="CPA1" /> [[Image:1CPXhydroxybridge.png|150 px|left|thumb|Figure 4: Hydroxy-bridge between catalytic and inhibitory zinc ions. The catalytic Zn<sup>2+</sup> ion (shown in orange on the right) is bridged to the inhibitory Zn<sup>2+</sup> ion (shown in orange on the left) by a OH<sup>-</sup> (shown in red).]] In the CPA structure containing only the catalytic Zn<sup>2+</sup> ion (3CPA), a water molecule complexed to the zinc is able to be deprotonated by <scene name='69/694222/3cpas1subsiteglu270/3'>Glu270</scene> to allow for normal initiation of hydrolysis. Again, this water molecule was not crystallized in the structure of 3CPA, but it is shown in Figure 3. However, when <scene name='69/694222/Glu270wiz/8'>the inhibitory zinc ion</scene> is also present ([http://www.rcsb.org/pdb/explore/explore.do?structureId=1cpx 1CPX]), it occupies the physical space that would normally be occupied by the water molecule. Thus, the inhibitory Zn<sup>2+</sup> ion interacts with the carboxylate group of Glu270. The Glu270 (shown in yellow) now simply stabilizes the second Zn<sup>2+</sup> and is unable to perform its usual base catalyst role while the catalytic Zn<sup>2+</sup> ion (shown in cyan) is still being stabilized in place by His69, Glu72, and His196 (shown in orange).
==Other Inhibitors==
==Other Inhibitors==

Revision as of 13:19, 18 April 2017

This Sandbox is Reserved from 02/09/2015, through 05/31/2016 for use in the course "CH462: Biochemistry 2" taught by Geoffrey C. Hoops at the Butler University. This reservation includes Sandbox Reserved 1051 through Sandbox Reserved 1080.
To get started:
  • Click the edit this page tab at the top. Save the page after each step, then edit it again.
  • Click the 3D button (when editing, above the wikitext box) to insert Jmol.
  • show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page.
  • Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc.

More help: Help:Editing

Carboxypeptidase A in Bos taurus

Bovine carboxypeptidase A (CPA)

Drag the structure with the mouse to rotate

References

  1. 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 Bukrinsky JT, Bjerrum MJ, Kadziola A. 1998. Native carboxypeptidase A in a new crystal environment reveals a different conformation of the important tyrosine 248. Biochemistry. 37(47):16555-16564. DOI: 10.1021/bi981678i
  2. 2.0 2.1 2.2 2.3 2.4 2.5 2.6 Christianson DW, Lipscomb WN. 1989. Carboxypeptidase A. Acc. Chem. Res. 22:62-69.
  3. Suh J, Cho W, Chung S. 1985. Carboxypeptidase A-catalyzed hydrolysis of α-(acylamino)cinnamoyl derivatives of L-β-phenyllactate and L-phenylalaninate: evidence for acyl-enzyme intermediates. J. Am. Chem. Soc. 107:4530-4535. DOI: 10.1021/ja00301a025
  4. Geoghegan, KF, Galdes, A, Martinelli, RA, Holmquist, B, Auld, DS, Vallee, BL. 1983. Cryospectroscopy of intermediates in the mechanism of carboxypeptidase A. Biochem. 22(9):2255-2262. DOI: 10.1021/bi00278a031
  5. Kaplan, AP, Bartlett, PA. 1991. Synthesis and evaluation of an inhibitor of carboxypeptidase A with a Ki value in the femtomolar range. Biochem. 30(33):8165-8170. PMID: 1868091
  6. Worthington, K., Worthington, V. 1993. Worthington Enzyme Manual: Enzymes and Related Biochemicals. Freehold (NJ): Worthington Biochemical Corporation; [2011; accessed March 28, 2017]. Carboxypeptidase A. http://www.worthington-biochem.com/COA/
  7. Pitout, MJ, Nel, W. 1969. The inhibitory effect of ochratoxin a on bovine carboxypeptidase a in vitro. Biochem. Pharma. 18(8):1837-1843. DOI: 0.1016/0006-2952(69)90279-2
  8. Normant, E, Martres, MP, Schwartz, JC, Gros, C. 1995. Purification, cDNA cloning, functional expression, and characterization of a 26-kDa endogenous mammalian carboxypeptidase inhibitor. Proc. Natl. Acad. Sci. 92(26):12225-12229. PMCID: PMC40329

Student Contributors

  • Thomas Baldwin
  • Michael Melbardis
  • Clay Schnell
Personal tools